Dodekin

N/A

Report date: 2023/11/01 20:08:59

Base Information

Drug NameDodekin

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionInterleukin-2 stimulants

TargetsInterleukin-2

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryItalyGermanySwitzerland

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesPhilogen Spa

China Registration ClassN/A

Active CompaniesPhilogen Spa

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

ATC CodeN/A